Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-03-22
1986-04-29
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
2602393B, A61K 3155, C07D28110
Patent
active
045857687
ABSTRACT:
Novel 1,5-benzothiazepine derivatives of the formula: ##STR1## wherein R.sup.1 is hydrogen or lower alkyl, R.sup.2 is hydrogen, lower alkanoyl or benzyl, R.sup.3 is hydrogen or lower alkyl and either one of R.sup.4 and R.sup.5 is hydrogen and the other is chlorine, or a pharmaceutically acceptable acid addition salt thereof are disclosed. Said derivative (I) and its salt have a potent platelet aggregation-inhibiting activity.
REFERENCES:
patent: 3075967 (1963-01-01), Krapcho
patent: 3341519 (1967-09-01), Krapcho
patent: 3562257 (1971-02-01), Kugita et al.
Murphy et al. "Proceedings National Academy of Sciences (USA)" (1983) vol. 80, No. 3, pp. 860-864.
"Circulation Research Supp. I.," Calcium Channel-Blocking Drugs, vol. 52, pp. I-115-I-119, 1983 (Kiyomoto, et al.).
Nagao Taku
Nakajima Hiromichi
Oh-ishi Tokuro
Takeda Mikio
Bond Robert T.
Tanabe Seiyaku Co. Ltd.
LandOfFree
1,5-benzothiazepine derivatives and processes for preparing the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,5-benzothiazepine derivatives and processes for preparing the , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,5-benzothiazepine derivatives and processes for preparing the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-141857